Abstract
Accurate clinical staging of cervical cancer before treatment is very important for making treatment decisions, monitoring therapy effect, forecasting the prognosis, and adjusting treatment plan. The metabolic changes in the primary tumor and metastases of cervical cancer could be clearly detected by 18F-FDG PET/CT whole body imaging, which helps to guide the clinical staging, treatment options, and is conducive to monitoring the therapeutic efficacy and prognosis. Key words: Uterine cervical neoplasms; Tomography, emission-computed; Tomography, X-ray computed; Deoxyglucose
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Chinese Journal of Nuclear Medicine and Molecular Imaging
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
